Clinical trialPhase 1 / Phase 2Unknown
Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas
- Outcome
- Outcome unknown
- Phase
- Phase 1 / Phase 2
- Status
- Unknown
- Study type
- Interventional
- Start
- April 2016
- Expected end
- June 2018
- Enrollment
- 60 participants
- Sites
- 1
- Primary outcomes
- 60 patients of refractory neoplasms in liver and pancreas with irreversible electroporation-related effectivity as assessed by MRI
- Sponsor
- Other
- Results posted
- No
- Last update
- 4 July 2016
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The pupose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for refractory neoplasms in liver and pancreas, the investigators used preoperative and postoperative US/CEUS/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.
Papers 7
- Registry-listed results paperBile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Labo… DOI 10.1016/j.jvir.2015.10.002↗
- Registry-listed results paperTreatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: genera… DOI 10.4149/213_150611n326↗
- Builds on itIrreversible electroporation ablation of end-stage metastatic retroperitoneal lesions: Report on three cases and litera… DOI 10.3892/etm.2019.7780↗
- BackgroundPercutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally… DOI 10.1016/j.ijsu.2015.06.049↗
- BackgroundLiver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures. DOI 10.1053/j.tvir.2015.06.004↗
- BackgroundSafety and feasibility of Irreversible Electroporation (IRE) in patients with locally advanced pancreatic cancer: resul… DOI 10.1159/000375323↗
- BackgroundPercutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a… DOI 10.1016/j.jvir.2014.04.007↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.